These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 37351170)
61. Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans. von Walden F; Fernandez-Gonzalo R; Norrbom J; Emanuelsson EB; Figueiredo VC; Gidlund EK; Norrbrand L; Liu C; Sandström P; Hansson B; Wan J; Cohen P; Alkner B J Appl Physiol (1985); 2021 Sep; 131(3):1035-1042. PubMed ID: 34351816 [TBL] [Abstract][Full Text] [Related]
62. Humanin, a Mitochondrial-Derived Peptide Released by Astrocytes, Prevents Synapse Loss in Hippocampal Neurons. Zárate SC; Traetta ME; Codagnone MG; Seilicovich A; Reinés AG Front Aging Neurosci; 2019; 11():123. PubMed ID: 31214013 [TBL] [Abstract][Full Text] [Related]
63. Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. Zhai D; Luciano F; Zhu X; Guo B; Satterthwait AC; Reed JC J Biol Chem; 2005 Apr; 280(16):15815-24. PubMed ID: 15661737 [TBL] [Abstract][Full Text] [Related]
64. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response. Dastidar SG; Pham MT; Mitchell MB; Yeom SG; Jordan S; Chang A; Sopher BL; La Spada AR J Neurosci; 2020 Nov; 40(45):8734-8745. PubMed ID: 33046555 [TBL] [Abstract][Full Text] [Related]
65. α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo. Ding Y; Kong D; Zhou T; Yang ND; Xin C; Xu J; Wang Q; Zhang H; Wu Q; Lu X; Lim K; Ma B; Zhang C; Li L; Huang W Neuromolecular Med; 2020 Mar; 22(1):56-67. PubMed ID: 31401719 [TBL] [Abstract][Full Text] [Related]
66. Mitochondria: A Therapeutic Target for Parkinson's Disease? Luo Y; Hoffer A; Hoffer B; Qi X Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618 [TBL] [Abstract][Full Text] [Related]
68. Endoplasmic reticulum-mitochondrial crosstalk: a novel role for the mitochondrial peptide humanin. Sreekumar PG; Hinton DR; Kannan R Neural Regen Res; 2017 Jan; 12(1):35-38. PubMed ID: 28250736 [TBL] [Abstract][Full Text] [Related]
69. Humanin decreases mitochondrial membrane permeability by inhibiting the membrane association and oligomerization of Bax and Bid proteins. Ma ZW; Liu DX Acta Pharmacol Sin; 2018 Jun; 39(6):1012-1021. PubMed ID: 29265109 [TBL] [Abstract][Full Text] [Related]
70. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease. Yalçınkaya N; Haytural H; Bilgiç B; Özdemir Ö; Hanağası H; Küçükali Cİ; Özbek Z; Akcan U; İdrisoğlu HA; Gürvit H; Tüzün E Neurosci Lett; 2016 Feb; 615():72-7. PubMed ID: 26806867 [TBL] [Abstract][Full Text] [Related]
71. Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Wang W; Wang X; Fujioka H; Hoppel C; Whone AL; Caldwell MA; Cullen PJ; Liu J; Zhu X Nat Med; 2016 Jan; 22(1):54-63. PubMed ID: 26618722 [TBL] [Abstract][Full Text] [Related]
72. A novel nanoparticle system targeting damaged mitochondria for the treatment of Parkinson's disease. Chen Y; Zhang B; Yu L; Zhang J; Zhao Y; Yao L; Yan H; Tian W Biomater Adv; 2022 Jul; 138():212876. PubMed ID: 35913233 [TBL] [Abstract][Full Text] [Related]
73. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. Tajima H; Kawasumi M; Chiba T; Yamada M; Yamashita K; Nawa M; Kita Y; Kouyama K; Aiso S; Matsuoka M; Niikura T; Nishimoto I J Neurosci Res; 2005 Mar; 79(5):714-23. PubMed ID: 15678515 [TBL] [Abstract][Full Text] [Related]
74. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation. Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038 [TBL] [Abstract][Full Text] [Related]
75. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Mani S; Sevanan M; Krishnamoorthy A; Sekar S Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241 [TBL] [Abstract][Full Text] [Related]
76. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling. Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA Cells; 2020 Mar; 9(3):. PubMed ID: 32192190 [No Abstract] [Full Text] [Related]
77. Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway. Yue P; Gao L; Wang X; Ding X; Teng J Neurochem Res; 2017 May; 42(5):1366-1374. PubMed ID: 28247332 [TBL] [Abstract][Full Text] [Related]
78. Protective mechanism of Wnt4 gene on Parkinson's disease (PD) transgenic Drosophila. Wu W; Han Y; Fan X; Li Q; Sun L Int J Neurosci; 2019 Jul; 129(7):703-714. PubMed ID: 30526176 [TBL] [Abstract][Full Text] [Related]
79. High-intensity interval exercise increases humanin, a mitochondrial encoded peptide, in the plasma and muscle of men. Woodhead JST; D'Souza RF; Hedges CP; Wan J; Berridge MV; Cameron-Smith D; Cohen P; Hickey AJR; Mitchell CJ; Merry TL J Appl Physiol (1985); 2020 May; 128(5):1346-1354. PubMed ID: 32271093 [TBL] [Abstract][Full Text] [Related]
80. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease. Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]